Wikidata entity: Q221174
C₁₂H₂₁NO₈S (P274)
Quantities
| P4250 | defined daily dose | 0.3 |
| P2067 | mass | 339.099 |
| P3780 | active ingredient in | ... | Q47522053 (Qudexy) | Qudexy |
| P3780 | active ingredient in | ... | Q47522216 (Topamax) | Topamax |
| P3780 | active ingredient in | ... | Q47522236 (Trokendi) | Trokendi |
| P3780 | active ingredient in | ... | Q48829128 (Topiragen) | Topiragen |
| P233 | canonical SMILES | String | CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C | ??? |
| P373 | Commons category | String | Topiramate | ??? |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q131755 (bipolar disorder) | bipolar disorder |
| P2175 | medical condition treated | ... | Q202387 (post-traumatic stress disorder) | post-traumatic stress disorder |
| P2175 | medical condition treated | ... | Q188638 (mood disorder) | mood disorder |
| P2175 | medical condition treated | ... | Q133823 (migraine) | migraine |
| P2175 | medical condition treated | ... | Q693519 (essential tremor) | essential tremor |
| P2175 | medical condition treated | ... | Q1406803 (tonic–clonic seizure) | tonic–clonic seizure |
| P2175 | medical condition treated | ... | Q7140388 (focal epilepsy) | focal epilepsy |
| P2175 | medical condition treated | ... | Q18553762 (migraine with aura) | migraine with aura |
| P2175 | medical condition treated | ... | Q18555095 (infantile epileptic encephalopathy) | infantile epileptic encephalopathy |
| P2175 | medical condition treated | ... | Q18558125 (intracranial hypertension) | intracranial hypertension |
| P129 | physically interacts with | ... | Q1486720 (Glutamate ionotropic receptor AMPA type subunit 3) | Glutamate ionotropic receptor AMPA type subunit 3 |
| P129 | physically interacts with | ... | Q3459294 (Sodium voltage-gated channel alpha subunit 5) | Sodium voltage-gated channel alpha subunit 5 |
| P129 | physically interacts with | ... | Q5038044 (Carbonic anhydrase 4) | Carbonic anhydrase 4 |
| P129 | physically interacts with | ... | Q5512777 (Gamma-aminobutyric acid type A receptor subunit alpha4) | Gamma-aminobutyric acid type A receptor subunit alpha4 |
| P129 | physically interacts with | ... | Q6981557 (Sodium voltage-gated channel alpha subunit 4) | Sodium voltage-gated channel alpha subunit 4 |
| P129 | physically interacts with | ... | Q6981560 (Sodium voltage-gated channel alpha subunit 9) | Sodium voltage-gated channel alpha subunit 9 |
| P129 | physically interacts with | ... | Q6981561 (Sodium voltage-gated channel alpha subunit 11) | Sodium voltage-gated channel alpha subunit 11 |
| P129 | physically interacts with | ... | Q21108701 (Glutamate ionotropic receptor kainate type subunit 1) | Glutamate ionotropic receptor kainate type subunit 1 |
| P129 | physically interacts with | ... | Q21108705 (Glutamate ionotropic receptor kainate type subunit 3) | Glutamate ionotropic receptor kainate type subunit 3 |
| P129 | physically interacts with | ... | Q21108706 (Glutamate ionotropic receptor kainate type subunit 4) | Glutamate ionotropic receptor kainate type subunit 4 |
| P129 | physically interacts with | ... | Q21113297 (Gamma-aminobutyric acid type A receptor subunit delta) | Gamma-aminobutyric acid type A receptor subunit delta |
| P129 | physically interacts with | ... | Q21113305 (Gamma-aminobutyric acid type A receptor subunit gamma2) | Gamma-aminobutyric acid type A receptor subunit gamma2 |
| P129 | physically interacts with | ... | Q21113312 (Gamma-aminobutyric acid type A receptor subunit beta3) | Gamma-aminobutyric acid type A receptor subunit beta3 |
| P129 | physically interacts with | ... | Q21113314 (Gamma-aminobutyric acid type A receptor subunit beta2) | Gamma-aminobutyric acid type A receptor subunit beta2 |
| P129 | physically interacts with | ... | Q21113326 (Gamma-aminobutyric acid type A receptor subunit gamma1) | Gamma-aminobutyric acid type A receptor subunit gamma1 |
| P129 | physically interacts with | ... | Q21113337 (Gamma-aminobutyric acid type A receptor subunit theta) | Gamma-aminobutyric acid type A receptor subunit theta |
| P129 | physically interacts with | ... | Q21113344 (Glutamate ionotropic receptor kainate type subunit 2) | Glutamate ionotropic receptor kainate type subunit 2 |
| P129 | physically interacts with | ... | Q21113351 (Glutamate ionotropic receptor kainate type subunit 5) | Glutamate ionotropic receptor kainate type subunit 5 |
| P129 | physically interacts with | ... | Q21114574 (Gamma-aminobutyric acid type A receptor subunit beta1) | Gamma-aminobutyric acid type A receptor subunit beta1 |
| P129 | physically interacts with | ... | Q21114578 (Gamma-aminobutyric acid type A receptor subunit alpha3) | Gamma-aminobutyric acid type A receptor subunit alpha3 |
| P129 | physically interacts with | ... | Q21115961 (Glutamate ionotropic receptor AMPA type subunit 1) | Glutamate ionotropic receptor AMPA type subunit 1 |
| P129 | physically interacts with | ... | Q21116946 (Carbonic anhydrase 12) | Carbonic anhydrase 12 |
| P129 | physically interacts with | ... | Q21126314 (sodium voltage-gated channel alpha subunit 1) | sodium voltage-gated channel alpha subunit 1 |
| P129 | physically interacts with | ... | Q21126334 (Sodium voltage-gated channel alpha subunit 10) | Sodium voltage-gated channel alpha subunit 10 |
| P129 | physically interacts with | ... | Q21132911 (Carbonic anhydrase 2) | Carbonic anhydrase 2 |
| P129 | physically interacts with | ... | Q21132915 (Carbonic anhydrase 7) | Carbonic anhydrase 7 |
| P129 | physically interacts with | ... | Q21135448 (Sodium voltage-gated channel alpha subunit 2) | Sodium voltage-gated channel alpha subunit 2 |
| P129 | physically interacts with | ... | Q21135449 (Sodium voltage-gated channel alpha subunit 3) | Sodium voltage-gated channel alpha subunit 3 |
| P129 | physically interacts with | ... | Q21173164 (Carbonic anhydrase 1) | Carbonic anhydrase 1 |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P279 | subclass of | ... | Q126615356 (2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate) | 2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate |
| P2868 | subject has role | ... | Q414238 (carbonic anhydrase inhibitor) | carbonic anhydrase inhibitor |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q1303753 (anti-obesity medication) | anti-obesity medication |
| P2868 | subject has role | ... | Q50377190 (neuroprotective agent) | neuroprotective agent |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | topiramate | ??? |
Why not click here or view trends?
log id: 1613324